IL6 and systemic lupus erythematosus: Aberrant IL-6 expression or signaling contributes to numerous diseases, including inflammatory and lymphoproliferative disorders such as giant cell arteritis, multiple myeloma, rheumatoid arthritis, and systemic lupus erythematosus (SLE) (88).